Shukra Pharmaceuticals Ltd reports Q2 FY27 revenue of ₹44.20 crore and net profit of ₹16.01 crore
- Revenue rose 652% YoY; net profit increased 573% YoY.
- EBITDA was ₹22.01 crore, at a 49.8% margin, versus negative EBITDA in Q2 FY26.
- Profit before tax was ₹21.13 crore, compared with ₹0.20 crore a year earlier.
